Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23

Chiara Degirolamo, Carlo Sabbà, Antonio Moschetta

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

The endocrine fibroblast growth factors (FGFs), FGF19, FGF21 and FGF23, are critical for maintaining whole-body homeostasis, with roles in bile acid, glucose and lipid metabolism, modulation of vitamin D and phosphate homeostasis and metabolic adaptation during fasting. Given these functions, the endocrine FGFs have therapeutic potential in a wide array of chronic human diseases, including obesity, type 2 diabetes, cancer, and kidney and cardiovascular disease. However, the safety and feasibility of chronic endocrine FGF administration has been challenged, and FGF analogues and mimetics are now being investigated. Here, we discuss current knowledge of the complex biology of the endocrine FGFs and assess how this may be harnessed therapeutically.

Original languageEnglish (US)
Pages (from-to)51-69
Number of pages19
JournalNature Reviews Drug Discovery
Volume15
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Fibroblast Growth Factors
Homeostasis
Therapeutics
Kidney Neoplasms
Kidney Diseases
Bile Acids and Salts
Lipid Metabolism
Vitamin D
Type 2 Diabetes Mellitus
Fasting
Chronic Disease
Cardiovascular Diseases
Obesity
Phosphates
fibroblast growth factor 21
Safety
Glucose

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology

Cite this

Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23. / Degirolamo, Chiara; Sabbà, Carlo; Moschetta, Antonio.

In: Nature Reviews Drug Discovery, Vol. 15, No. 1, 01.01.2016, p. 51-69.

Research output: Contribution to journalArticle

Degirolamo, Chiara ; Sabbà, Carlo ; Moschetta, Antonio. / Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23. In: Nature Reviews Drug Discovery. 2016 ; Vol. 15, No. 1. pp. 51-69.
@article{645a42bd146047fa9aeab150decf0fa7,
title = "Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23",
abstract = "The endocrine fibroblast growth factors (FGFs), FGF19, FGF21 and FGF23, are critical for maintaining whole-body homeostasis, with roles in bile acid, glucose and lipid metabolism, modulation of vitamin D and phosphate homeostasis and metabolic adaptation during fasting. Given these functions, the endocrine FGFs have therapeutic potential in a wide array of chronic human diseases, including obesity, type 2 diabetes, cancer, and kidney and cardiovascular disease. However, the safety and feasibility of chronic endocrine FGF administration has been challenged, and FGF analogues and mimetics are now being investigated. Here, we discuss current knowledge of the complex biology of the endocrine FGFs and assess how this may be harnessed therapeutically.",
author = "Chiara Degirolamo and Carlo Sabb{\`a} and Antonio Moschetta",
year = "2016",
month = "1",
day = "1",
doi = "10.1038/nrd.2015.9",
language = "English (US)",
volume = "15",
pages = "51--69",
journal = "Nature Reviews Drug Discovery",
issn = "1474-1776",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23

AU - Degirolamo, Chiara

AU - Sabbà, Carlo

AU - Moschetta, Antonio

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The endocrine fibroblast growth factors (FGFs), FGF19, FGF21 and FGF23, are critical for maintaining whole-body homeostasis, with roles in bile acid, glucose and lipid metabolism, modulation of vitamin D and phosphate homeostasis and metabolic adaptation during fasting. Given these functions, the endocrine FGFs have therapeutic potential in a wide array of chronic human diseases, including obesity, type 2 diabetes, cancer, and kidney and cardiovascular disease. However, the safety and feasibility of chronic endocrine FGF administration has been challenged, and FGF analogues and mimetics are now being investigated. Here, we discuss current knowledge of the complex biology of the endocrine FGFs and assess how this may be harnessed therapeutically.

AB - The endocrine fibroblast growth factors (FGFs), FGF19, FGF21 and FGF23, are critical for maintaining whole-body homeostasis, with roles in bile acid, glucose and lipid metabolism, modulation of vitamin D and phosphate homeostasis and metabolic adaptation during fasting. Given these functions, the endocrine FGFs have therapeutic potential in a wide array of chronic human diseases, including obesity, type 2 diabetes, cancer, and kidney and cardiovascular disease. However, the safety and feasibility of chronic endocrine FGF administration has been challenged, and FGF analogues and mimetics are now being investigated. Here, we discuss current knowledge of the complex biology of the endocrine FGFs and assess how this may be harnessed therapeutically.

UR - http://www.scopus.com/inward/record.url?scp=84955209323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955209323&partnerID=8YFLogxK

U2 - 10.1038/nrd.2015.9

DO - 10.1038/nrd.2015.9

M3 - Article

C2 - 26567701

AN - SCOPUS:84955209323

VL - 15

SP - 51

EP - 69

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

SN - 1474-1776

IS - 1

ER -